ARCHIVES

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities

September 22, 1978

Cancer Meetings Listed For Next Three Months

September 20, 1996